EC
ECXWW
ECARX Holdings Inc.
$0.0601
0.00%
$15.2M
No data for this timeframe.
Vol
Market Cap$15.2M
Cap SizeNano Cap
SEC Reports5
Exchange Nasdaq·Sector Services-Computer Integrated Systems Design·CIK 0001861974·Prev Close $0.0601
Recent Activity
Jun 1, 2026
SEC
ECARX announced a binding memorandum of business cooperation with TPK Holding to co-develop the ORCA LiDAR platform, mar
6-K — Impact 4/10
May 19, 2026
SEC
ECARX reported Q1 2026 revenue of $131.5M, down 22% YoY, driven by a one-time software license revenue compare and lower
6-K — Impact 5/10
May 19, 2026
SEC
ECARX announced a strategic framework agreement with May Mobility to develop L4 autonomous ride-hail vehicles, targeting
6-K — Impact 6/10
Latest Reports
NEUTRAL
6-K
4/10
ECARX announced a binding memorandum of business cooperation with TPK Holding to co-develop the ORCA LiDAR platform, mar
Jun 1, 2026
BEARISH
6-K
5/10
ECARX reported Q1 2026 revenue of $131.5M, down 22% YoY, driven by a one-time software license revenue compare and lower
May 19, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 1 mixed, 2 neutral. Avg impact: 5.2/10.
NEUTRAL
6-K
4/10
ECARX announced a binding memorandum of business cooperation with TPK Holding to co-develop the ORCA
Jun 1, 2026
BEARISH
6-K
5/10
ECARX reported Q1 2026 revenue of $131.5M, down 22% YoY, driven by a one-time software license reven
May 19, 2026
BULLISH
6-K
6/10
ECARX announced a strategic framework agreement with May Mobility to develop L4 autonomous ride-hail
May 19, 2026
NEUTRAL
6-K
5/10
ECARX Holdings announced a preliminary plan to acquire a minority stake and key IP assets, including
Apr 8, 2026
MIXED
20-F
6/10
ECARX Holdings Inc. reported its 2025 annual results, showing continued revenue growth of 10% to $84
Mar 30, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 45.6% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 42.8% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.1B | 32.4% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.4B | 22.8% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.